Equillium Inc

Company Profile

Equillium Inc had its IPO on 2018-10-11 under the ticker symbol EQ.

The company operates in the Healthcare sector and Biotechnology industry. Equillium Inc has a staff strength of 37 employees.

Stock update

Shares of Equillium Inc opened at $0.8 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.8 - $0.82, and closed at $0.8.

This is a -0.51% slip from the previous day's closing price.

A total volume of 65,975 shares were traded at the close of the day’s session.

In the last one week, shares of Equillium Inc have increased by +0.75%.

Equillium Inc's Key Ratios

Equillium Inc has a market cap of $21.85 million, indicating a price to book ratio of 1.4883 and a price to sales ratio of 0.

In the last 12-months Equillium Inc’s revenue was $24.64 million with a gross profit of $15.76 million and an EBITDA of $-28731000. The EBITDA ratio measures Equillium Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Equillium Inc’s operating margin was -117.12% while its return on assets stood at -24.7% with a return of equity of -70.7%.

In Q1, Equillium Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Equillium Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.76 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Equillium Inc’s profitability.

Equillium Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -0.1214. Its price to sales ratio in the trailing 12-months stood at 0.

Equillium Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$71.79 million

Total Liabilities

$32.02 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Equillium Inc ended 2024 with $71.79 million in total assets and $0 in total liabilities. Its intangible assets were valued at $71.79 million while shareholder equity stood at $29.27 million.

Equillium Inc ended 2024 with $0 in deferred long-term liabilities, $32.02 million in other current liabilities, 3000.00 in common stock, $-176345000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $24.50 million and cash and short-term investments were $61.99 million. The company’s total short-term debt was $6,118,000 while long-term debt stood at $1.84 million.

Equillium Inc’s total current assets stands at $70.22 million while long-term investments were $0 and short-term investments were $37.49 million. Its net receivables were $3.42 million compared to accounts payable of $5.69 million and inventory worth $0.

In 2024, Equillium Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Equillium Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.8

52-Week High

$3.2

52-Week Low

$0.48

Analyst Target Price

$4.67

Equillium Inc stock is currently trading at $0.8 per share. It touched a 52-week high of $3.2 and a 52-week low of $3.2. Analysts tracking the stock have a 12-month average target price of $4.67.

Its 50-day moving average was $0.81 and 200-day moving average was $0.87 The short ratio stood at 2.93 indicating a short percent outstanding of 0%.

Around 3188.8% of the company’s stock are held by insiders while 3030.1% are held by institutions.